Products & Services · Total Revenue
TECFIDERA — Total Revenue
Biogen TECFIDERA — Total Revenue decreased by 2.1% to $109.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 46.9%, from $206.10M to $109.50M. Over 3 years (FY 2022 to FY 2025), TECFIDERA — Total Revenue shows a downward trend with a -22.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ2 2017
Last reportedQ1 2026
Rolls up toTotal Revenue
How to read this metric
An increase indicates strong market demand and successful commercialization, while a decrease suggests competitive pressure or patent expirations.
Detailed definition
Represents the total gross sales generated from the Tecfidera product line, net of returns, allowances, and rebates. Thi...
Peer comparison
Standard revenue reporting for specific pharmaceutical products across major biotech peers.
Metric ID:
biib_segment_tecfidera_total_revenueHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $487.60M | $498.60M | $409.90M | $397.90M | $339.00M | $297.10M | $274.50M | $254.20M | $239.50M | $244.30M | $254.30M | $252.20M | $232.80M | $227.80M | $206.10M | $193.60M | $168.20M | $111.80M | $109.50M |
| QoQ Change | — | +2.3% | -17.8% | -2.9% | -14.8% | -12.4% | -7.6% | -7.4% | -5.8% | +2.0% | +4.1% | -0.8% | -7.7% | -2.1% | -9.5% | -6.1% | -13.1% | -33.5% | -2.1% |
| YoY Change | — | — | — | -18.4% | -32.0% | — | -33.0% | -36.1% | -29.4% | -17.8% | -7.4% | -0.8% | -2.8% | -6.8% | -19.0% | -23.2% | -27.7% | -50.9% | -46.9% |
Range$109.50M – $498.60M
CAGR-28.2%
Avg YoY Growth-23.5%
Median YoY Growth-23.2%
Current Streak8 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Biogen's tecfidera — total revenue?
- Biogen (BIIB) reported tecfidera — total revenue of $109.50M in Q1 2026.
- How has Biogen's tecfidera — total revenue changed year-over-year?
- Biogen's tecfidera — total revenue decreased by 46.9% year-over-year, from $206.10M to $109.50M.
- What is the long-term trend for Biogen's tecfidera — total revenue?
- Over 3 years (2022 to 2025), Biogen's tecfidera — total revenue has grown at a -22.2% compound annual growth rate (CAGR), from $1.44B to $679.70M.
- What does tecfidera — total revenue mean?
- The total amount of money earned from selling the Tecfidera drug.